Dr. William L. (Bill) Macias has over 25 years of years of pharmaceutical experience including early, mid and late phase drug development. He has led multiple clinical development programs leading to the submission and approval of medications across diverse therapeutic areas (critical care, cardiology, and immunology) in both biologic and small molecules.
Bill is a drug development consultant and CEO of Focus Biomedical Consulting LLC. He joined Promethera as a consultant in 2019 and as interim CMO in 2020. He had previously been a Distinguished Medical Fellow and a member of senior management at Eli Lilly and Company.
Bill earned his Doctor of Medicine and Doctor of Philosophy (Physiology) at Indiana University School of Medicine. He held board certifications in Internal Medicine, Nephrology, and Critical Care Medicine.